The application of physiologically based pharmacokinetic modelling in the analysis of occupational exposure to perchloroethylene

被引:5
|
作者
Loizou, GD [1 ]
机构
[1] Hlth & Safety Lab, Sheffield S3 7HQ, S Yorkshire, England
关键词
perchloroethylene; occupational; exposure; PBPK; modeling;
D O I
10.1016/S0378-4274(00)00283-6
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
A physiologically based pharmacokinetic model for perchloroethylene was parameterized, calibrated and validated using anatomic, physiologic, biochemical and physicochemical data obtained from the literature. The model was used to analyse human exposure data obtained under controlled conditions and from dry cleaning establishments in the Padua area of northern Italy. Whilst the model satisfactorily simulated the urinary excretion of trichloroacetic acid, following experimental inhalation exposure to 10, 20 and 40 ppm perchloroethylene under controlled conditions the opposite was true for the occupational exposure data. However, further model refinement to incorporate inter-individual variability of anatomical, physiological and biochemical parameters which have an impact on model output, would further improve the predictive capabilities of the model. The possibility of perchloroethylene and trichloroethylene co-exposure in the occupational setting was indicated by the model. Crown Copyright (C) 2001 Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:59 / 69
页数:11
相关论文
共 50 条
  • [41] Physiologically Based Pharmacokinetic Modeling of Nanoparticles
    Yuan, Dongfen
    He, Hua
    Wu, Yun
    Fan, Jianghong
    Cao, Yanguang
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (01) : 58 - 72
  • [42] Physiologically-based Pharmacokinetic Modelling for the Reduction of Animal Use in the Discovery of Novel Pharmaceuticals
    Thomas, Simon
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2010, 38 : 81 - 85
  • [43] A Physiologically Based Pharmacokinetic Model to Predict Determinants of Variability in Epirubicin Exposure and Tissue Distribution
    Ansaar, Radwan
    Meech, Robyn
    Rowland, Andrew
    PHARMACEUTICS, 2023, 15 (04)
  • [44] Physiologically Based Pharmacokinetic Modeling of Nanoparticles
    Lu, Mingguang
    Al-Jamal, Khuloud T.
    Kostarelos, Kostas
    Reineke, Joshua
    ACS NANO, 2010, 4 (11) : 6303 - 6317
  • [45] Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models
    Chaphekar, Nupur
    Dodeja, Prerna
    Shaik, Imam H.
    Caritis, Steve
    Venkataramanan, Raman
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [46] Application of a Physiologically Based Pharmacokinetic Approach to Predict Tenofovir Pharmacokinetics During Pregnancy
    Abduljalil, Khaled
    Mendes, Mailys De Sousa
    Salem, Farzaneh
    Benaboud, Sihem
    Gardner, Iain
    AAPS JOURNAL, 2025, 27 (01):
  • [47] Real-world application of physiologically based pharmacokinetic models in drug discovery
    Santos, Laura G. A.
    Jaiswal, Swati
    Chen, Kuan-Fu
    Jones, Hannah M.
    Templeton, Ian E.
    DRUG METABOLISM AND DISPOSITION, 2025, 53 (01)
  • [48] Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Caffeine Disposition in Pregnancy
    Darakjian, Lucy I.
    Kaddoumi, Amal
    MOLECULAR PHARMACEUTICS, 2019, 16 (03) : 1340 - 1349
  • [49] Metabolism and physiologically based pharmacokinetic modeling of flumioxazin in pregnant animals
    Takaku, Tomoyuki
    Nagahori, Hirohisa
    Sogame, Yoshihisa
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2014, 277 (03) : 242 - 249
  • [50] Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles
    Deng, Linjing
    Liu, Hui
    Ma, Yongsheng
    Miao, Yufeng
    Fu, Xiaoli
    Deng, Qihong
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 384